2000 participants
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2026-07-20
- Start Date:
- 2024-07-22
- Completion:
- 2032-04-01
Conditions
- Relapsing Multiple Sclerosis
- Multiple Sclerosis
Interventions
- OTHER
No Results Yet